Cargando…

Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies

BACKGROUND: Patients with coronavirus disease 2019 (COVID-19) who have underlying malignancy have a higher mortality rate compared with those without cancer, although the magnitude of such excess risk is not clearly defined. We performed a systematic review and pooled analysis to provide precise est...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saini, Kamal S., Tagliamento, Marco, Lambertini, Matteo, McNally, Richard, Romano, Marco, Leone, Manuela, Curigliano, Giuseppe, de Azambuja, Evandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467090/ https://www.ncbi.nlm.nih.gov/pubmed/32971510 http://dx.doi.org/10.1016/j.ejca.2020.08.011

Ejemplares similares

Estimating Mortality in Patients with Hematological Malignancy and COVID-19: A Pooled Analysis of 10 Studies
por: Saini, Kamal S., et al.
Publicado: (2020)

Emerging issues related to COVID-19 vaccination in patients with cancer
por: Saini, Kamal S., et al.
Publicado: (2021)

Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review and meta-analysis
por: Tagliamento, Marco, et al.
Publicado: (2021)

Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy
por: Saini, Kamal S., et al.
Publicado: (2020)

Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis
por: Poggio, Francesca, et al.
Publicado: (2018)

Controversies in oncology: which adjuvant endocrine therapy is to be given to premenopausal patients with hormone receptor-positive breast cancer?
por: Lambertini, Matteo, et al.
Publicado: (2018)

Controversies in Oncology: Surgery of the primary tumour in patients presenting with de novo metastatic breast cancer: to do or not to do?
por: Poggio, Francesca, et al.
Publicado: (2018)

How I treat metastatic triple-negative breast cancer
por: Caparica, Rafael, et al.
Publicado: (2019)

Reply to: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer
por: Agostinetto, Elisa, et al.
Publicado: (2023)

Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis
por: Becerril-Gaitan, Andrea, et al.
Publicado: (2022)

Twenty years of anti-HER2 therapy-associated cardiotoxicity
por: Pondé, Noam F, et al.
Publicado: (2016)

Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months
por: de las Heras, Begoña, et al.
Publicado: (2020)

Oncofertility counselling in premenopausal women with HER2-positive breast cancer
por: Lambertini, Matteo, et al.
Publicado: (2019)

Is It Time for Coronavirus Disease-2019 Vaccine Mandates?
por: Bernstein, Henry H., et al.
Publicado: (2022)

Post-neoadjuvant treatment and the management of residual disease in breast cancer: state of the art and perspectives
por: Caparica, Rafael, et al.
Publicado: (2019)

Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
por: Kourie, Hampig Raphael, et al.
Publicado: (2017)

Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis
por: Henry, Brandon Michael, et al.
Publicado: (2020)

VISTA: A Promising Target for Cancer Immunotherapy?
por: Tagliamento, Marco, et al.
Publicado: (2021)

The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region
por: Trapani, Dario, et al.
Publicado: (2020)

Lessons learned at SABCS 2019 and to-dos from immunotherapy in breast cancer
por: Eiger, Daniel, et al.
Publicado: (2020)

The potential association between common comorbidities and severity and mortality of coronavirus disease 2019: A pooled analysis
por: Luo, Liman, et al.
Publicado: (2020)

Risk of coronavirus disease 2019 in patients treated for cancer: An immune response–based hypothesis
por: Roberto, Michela, et al.
Publicado: (2020)

ESMO Open: news in breast cancer 2019
por: Lambertini, Matteo
Publicado: (2020)

CERN Opendays 2019 - ME52
por: Brice, Maximilien, et al.
Publicado: (2019)

Gastrointestinal symptoms associated with severity of coronavirus disease 2019 (COVID-19): a pooled analysis
por: Henry, Brandon Michael, et al.
Publicado: (2020)

Biodiversity of 52 chicken populations assessed by microsatellite typing of DNA pools
por: Hillel, Jossi, et al.
Publicado: (2003)

Pooled prevalence of deep vein thrombosis among coronavirus disease 2019 patients
por: Wang, Ying, et al.
Publicado: (2020)

CERN Bulletin Issue No. 52-04/2019
Publicado: (2019)

CERN Bulletin Issue No. 52-4/2019
Publicado: (2019)

Effect of the COVID-19 pandemic on cancer treatment and research
por: Saini, Kamal S, et al.
Publicado: (2020)

Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019
por: Di Cosimo, Serena, et al.
Publicado: (2020)

Current State of the Art in the Adjuvant Systemic Treatment of Premenopausal Patients With Early Breast Cancer
por: Parisi, Francesca, et al.
Publicado: (2020)

Update on the Management of Breast Cancer during Pregnancy
por: Poggio, Francesca, et al.
Publicado: (2020)

Call for ensuring cancer care continuity during COVID-19 pandemic
por: Tagliamento, Marco, et al.
Publicado: (2020)

Famotidine and Mortality in Coronavirus Disease 2019
por: Sethia, Rahul, et al.
Publicado: (2021)

Predicting in-hospital mortality from Coronavirus Disease 2019: A simple validated app for clinical use
por: Magro, Bianca, et al.
Publicado: (2021)

Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis
por: Potere, Nicola, et al.
Publicado: (2020)

Cancer Patients and Risk of Mortality for COVID-19
por: Curigliano, Giuseppe
Publicado: (2020)

Association between D-Dimer levels and mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and pooled analysis
por: Sakka, M., et al.
Publicado: (2020)

Correction to Lancet Neurol 2019; 18: 942–52
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9fsejon1jbao5rbn8vn4ibvc59